About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2013 (2013), Article ID 195691, 12 pages
Clinical Study

Autologous CIK Cell Immunotherapy in Patients with Renal Cell Carcinoma after Radical Nephrectomy

1Biotherapeutic Department, Chinese PLA General Hospital, Beijing 100853, China
2Department of Cadre Health Care, Naval General Hospital, Beijing 100048, China

Received 30 September 2013; Accepted 13 November 2013

Academic Editor: Eyad Elkord

Copyright © 2013 Yajing Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [8 citations]

The following is the list of published articles that have cited the current article.

  • Zheng-Xu Wang, Jun-Li Li, Jun-Xia Cao, Yi-Shan Liu, Duo Li, Xiao-Yan Zhang, Min Wang, Min Wu, Bei-Lei Xu, Jin-Long Liu, and Hai-Bo Wang, “Cytokine-induced killer cells in the treatment of patients with renal cell carcinoma: a pooled meta-analysis,” Immunotherapy, vol. 6, no. 6, pp. 787–795, 2014. View at Publisher · View at Google Scholar
  • Ji Sung Kim, In Sung Chung, Sang Hee Lim, Yunsoo Park, Mi Jeong Park, Ju Young Kim, Yong Guk Kim, Jin Tae Hong, Youngsoo Kim, and Sang-Bae Han, “Preclinical and clinical studies on cytokine-induced killer cells for the treatment of renal cell carcinoma,” Archives of Pharmacal Research, 2014. View at Publisher · View at Google Scholar
  • Yajing Zhang, Lei Xia, Yan Zhang, Yao Wang, Xuechun Lu, Fengxia Shi, Yang Liu, Meixia Chen, Kaixhao Feng, Wenying Zhang, Xiaobing Fu, and Weidong Han, “Analysis of adverse events following the treatment of autologous cytokine-induced killer cells for adoptive immunotherapy in malignant tumour sufferers,” Expert Opinion on Biological Therapy, pp. 1–13, 2014. View at Publisher · View at Google Scholar
  • Hui Fan, Xuechun Lu, Xiaohui Wang, Yang Liu, Bo Guo, Yan Zhang, Wenying Zhang, Jing Nie, Kaichao Feng, Meixia Chen, Yajing Zhang, Yao Wang, Fengxia Shi, Xiaobing Fu, Hongli Zhu, and Weidong Han, “Low-Dose Decitabine-Based Chemoimmunotherapy for Patients with Refractory Advanced Solid Tumors: A Phase I/II Report,” Journal of Immunology Research, vol. 2014, pp. 1–14, 2014. View at Publisher · View at Google Scholar
  • Yelei Guo, and Weidong Han, “Cytokine-induced killer (CIK) cells: from basic research to clinical translation,” Chinese Journal of Cancer, vol. 34, no. 1, pp. 6, 2015. View at Publisher · View at Google Scholar
  • Sarah Oelsner, Juliane Wagner, Miriam E. Friede, Verena Pfirrmann, Sabrina Genßler, Eva Rettinger, Christian J. Buchholz, Heike Pfeifer, Ralf Schubert, Oliver G. Ottmann, Evelyn Ullrich, Peter Bader, and Winfried S. Wels, “Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival,” International Journal of Cancer, vol. 139, no. 8, pp. 1799–1809, 2016. View at Publisher · View at Google Scholar
  • Hejin Jia, Yaping Tian, Chao Guang Jiang, and Weidong Han, “Evaluation of 29 indicators for the prognosis of advanced non-small cell lung cancer with cytokine-induced killer cell therapy combined with chemother,” Experimental And Therapeutic Medicine, vol. 11, no. 5, pp. 1601–1610, 2016. View at Publisher · View at Google Scholar
  • L. Ma, Y. Wang, J. Bo, W. Han, Y. Wang, L. Zhang, X. Wu, S. Yu, and R. Liu, “Autologous cytokine-induced killer (CIK) cell immunotherapy combined with cyclophosphamide in five patients with POEMS syndrome,” Clinical & Experimental Immunology, vol. 184, no. 1, pp. 83–89, 2016. View at Publisher · View at Google Scholar